Efficacy of Gabapentin vs. Placebo for Adjuvant Pain Control Following Acute Rib Fractures

Completed · Early Phase 1

Conditions studied: Acute Pain

In brief

A Multi-center, Randomized Controlled Trial of the Efficacy of Gabapentin vs. Placebo for Adjutant Pain Control Following Acute Rib Fractures.

Key facts

Study ID

NCT02856750

Run by

Denver Health and Hospital Authority

People needed

100

Starts

2016-10-01

Expected to finish

2018-10-23

Last updated by the study team

2018-10-26

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• > 1 rib fractures
• Requiring hospital admission
• Enrolled within 24 hours of injury

You may not qualify if…

• Pregnancy
• Intubation
• Age <18, age >65
• Inability to tolerate PO medication
• Patient refusal
• Inability to obtain consent from patient or surrogate
• Renal or Hepatic impairment
• Allergy or Hypersensitivity to gabapentin or any component of the formulation

Where it is running

• Denver Health Medical Center — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.